Researchers have developed a new gene editing platform that will enable safer and more effective T cell-based immunotherapies ...

Veteran broadcaster Derryn Hinch has shared an update amid his ongoing health battles. After undergoing treatment for skin cancer and a heart issue in 2024, the 81-year-old has no ...

Regeneron's PD-1 inhibitor Libtayo hits the mark where MSD's Keytruda missed in a form of non-melanoma skin cancer.